Research from University of Medicine and Dentistry of New Jersey, Department of Medicine has provided new data on vascular disease clinical trial

Scientists discuss in 'The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease' new findings in vascular disease. According to recent research from the United States, "' Clinical management of two key modifiable risk factors for cardiovascular disease (CVD), hypertension and dyslipidemia, has evolved considerably over the past 40 years, in terms of the focus of therapy, available pharmacologic agents, and therapeutic targets. A brief review of the epidemiology of hypertension and hyperlipidemia and of controlled clinical trials of pharmacologic therapy of these conditions in decreasing cardiovascular events is presented. Risk factors for CVD generally do...

Want to see the full article?

• Purchase this article for only $3.00